Cronos Group (TSE:CRON) Shares Down 0.8% – Should You Sell?

Shares of Cronos Group Inc. (TSE:CRON) traded down 0.8% on Tuesday . The stock traded as low as C$3.84 and last traded at C$3.89. 83,617 shares traded hands during trading, a decline of 51% from the average daily volume of 169,685 shares. The stock had previously closed at C$3.92.

Analysts Set New Price Targets

Separately, TD lifted their price target on Cronos Group from C$4.50 to C$5.50 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. Three equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of C$4.75.

Cronos Group Stock Down 0.8%

The company has a market capitalization of C$1.45 billion, a P/E ratio of -188.00, a price-to-earnings-growth ratio of 0.12 and a beta of 1.13. The company has a current ratio of 21.87, a quick ratio of 24.01 and a debt-to-equity ratio of 0.12. The stock’s fifty day moving average is C$3.81 and its 200 day moving average is C$3.67.

Cronos Group (TSE:CRON) last announced its quarterly earnings results on Monday, May 11th. The company reported C$0.06 earnings per share (EPS) for the quarter. Cronos Group had a negative net margin of 1.29% and a negative return on equity of 0.19%. The business had revenue of C$62.86 million for the quarter. Research analysts predict that Cronos Group Inc. will post -0.26 EPS for the current fiscal year.

About Cronos Group

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S.